These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7611248)

  • 21. Early elevation of lipoprotein(a) levels in chronic renal insufficiency.
    De Lima JJ; Maranhão RC; Latrilha Mda C; Diament J; Romão JE; Krieger EM; Pileggi F
    Ren Fail; 1997 Jan; 19(1):145-54. PubMed ID: 9044461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) in renal disease.
    Kronenberg F; Utermann G; Dieplinger H
    Am J Kidney Dis; 1996 Jan; 27(1):1-25. PubMed ID: 8546123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
    Hernández E; Praga M; Alamo C; Araque A; Morales JM; Alcazar JM; Ruilope LM; Rodicio JL
    Nephron; 1996; 72(2):145-9. PubMed ID: 8684517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein (a) in patients on hemodialysis.
    Díaz-Peromingo JA; Carbajal DG; Albán-Salgado A
    Acta Med Austriaca; 2004 Aug; 31(3):73-5. PubMed ID: 15515480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
    Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF
    Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
    Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A
    Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of renal replacement therapy on plasma lipoprotein(a) levels.
    Rosas S; Joffe M; Wolfe M; Brayman K; Rader DJ
    Am J Nephrol; 2008; 28(3):361-5. PubMed ID: 18057868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.
    Goldwasser P; Michel MA; Collier J; Mittman N; Fein PA; Gusik SA; Avram MM
    Am J Kidney Dis; 1993 Jul; 22(1):215-25. PubMed ID: 8322786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An increased serum level of free Apo(a) in renal patients is more striking than that of Lp(a) and is influenced by homocysteine.
    Herrmann W; Quast S; Ellgass A; Wolter K; Kiessig ST; Molinari E; Riegel W
    Nephron; 2000 May; 85(1):41-9. PubMed ID: 10773754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased lipoprotein(a) concentrations in chronic renal failure.
    Haffner SM; Gruber KK; Aldrete G; Morales PA; Stern MP; Tuttle KR
    J Am Soc Nephrol; 1992 Nov; 3(5):1156-62. PubMed ID: 1482754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis.
    Topciu Shufta V; Begolli L; Kryeziu E
    Bosn J Basic Med Sci; 2010 Feb; 10(1):19-25. PubMed ID: 20192926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
    Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
    Greiber S; Wanner C
    Miner Electrolyte Metab; 1997; 23(3-6):161-5. PubMed ID: 9387108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.
    Kerschdorfer L; König P; Neyer U; Bösmüller C; Lhotta K; Auinger M; Hohenegger M; Riegler P; Margreiter R; Utermann G; Dieplinger H; Kronenberg F
    Atherosclerosis; 1999 Jun; 144(2):381-91. PubMed ID: 10407499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid parameters including Lp(a) in hemodialysis patients.
    Elisaf M; Bairaktari H; Tzallas C; Germanos N; Koulouridis E; Pappas M; Siamopoulos KC; Tsolas O
    Ren Fail; 1994; 16(4):501-9. PubMed ID: 7938758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.